Application 091416

Type: ANDA
Sponsor: MARKSANS PHARMA

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	NAPROXEN	NAPROXEN	TABLET;ORAL	250MG	No	No
002	NAPROXEN	NAPROXEN	TABLET;ORAL	375MG	No	No
003	NAPROXEN	NAPROXEN	TABLET;ORAL	500MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A091416-001	NAPROXEN	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14
A091416-002	NAPROXEN	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14
A091416-003	NAPROXEN	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A091416-001	AB
A091416-002	AB
A091416-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A091416-002	NAPROXEN	375MG	TABLET / ORAL	AB	2011-02-14	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A091416-003	NAPROXEN	500MG	TABLET / ORAL	AB	2011-02-14	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A091416-001	NAPROXEN	250MG	TABLET / ORAL	AB	2011-02-14	`301d65b070ca…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A091416-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091416-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A091416-003	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A091416-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091416-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A091416-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A091416-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091416-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A091416-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091416-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091416-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A091416-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A091416-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091416-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A091416-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091416-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091416-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A091416-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091416-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091416-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A091416-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091416-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091416-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A091416-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091416-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091416-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A091416-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091416-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091416-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A091416-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091416-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091416-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A091416-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A091416-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091416-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A091416-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A091416-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A091416-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A091416-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A091416-001	AB	1	`301d65b070ca…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 13 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NAPROXEN	NAPROXEN	Northwind Health Company, LLC	f32d755e-4984-ee40-e053-2995a90a4ebe	2026-01-01	Warnings	Exact identifier application applno (ANDA): 091416 application number: ANDA091416
NAPROXEN	NAPROXEN	QPharma Inc	c0a4839b-7154-c82c-e053-2a95a90a7e6d	2025-12-03	Warnings	Exact identifier application applno (ANDA): 091416 application number: ANDA091416
NAPROXEN	NAPROXEN	PD-Rx Pharmaceuticals, Inc.	a9f9ce81-9d51-4167-9581-974866a8fe31	2025-10-17	Warnings	Exact identifier application applno (ANDA): 091416 application number: ANDA091416
NAPROXEN	NAPROXEN	DIRECT RX	b1b78c49-82e9-2402-e053-2a95a90ae35f	2025-01-17	Warnings	Exact identifier application applno (ANDA): 091416 application number: ANDA091416 ndc (product): 72189-136
Naproxen	NAPROXEN	Advanced Rx of Tennessee, LLC	af9a96cf-1cda-8ace-e053-2a95a90a18cc	2024-12-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 091416 application number: ANDA091416 ndc (product): 80425-0048
Naproxen	NAPROXEN	MARKSANS PHARMA LIMITED	1fdb4cbd-e9e8-47bb-b3d8-1f1ec8f411c8	2024-12-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 091416 application number: ANDA091416
NAPROXEN	NAPROXEN	NuCare Pharmaceuticals,Inc.	5487dee2-5c37-4348-e054-00144ff8d46c	2024-07-17	Warnings	Exact identifier application applno (ANDA): 091416 application number: ANDA091416
NAPROXEN	NAPROXEN	NuCare Pharmaceuticals,Inc.	71d4a048-ca50-73db-e053-2a95a90ad465	2024-06-10	Warnings	Exact identifier application applno (ANDA): 091416 application number: ANDA091416
NAPROXEN	NAPROXEN	NuCare Pharmaceuticals,Inc.	69366b55-2687-17a4-e053-2a91aa0a65b3	2024-06-07		Exact identifier application applno (ANDA): 091416 application number: ANDA091416
NAPROXEN	NAPROXEN	Asclemed USA, Inc.	a4fcb411-c918-459b-adc6-06dfa8ed8a50	2022-10-12	Warnings	Exact identifier application applno (ANDA): 091416 application number: ANDA091416 ndc (product): 76420-042
NAPROXEN	NAPROXEN	Aphena Pharma Solutions - Tennessee, LLC	32693390-763b-46dd-b821-65a7bf3c6671	2021-04-26	Warnings	Exact identifier application applno (ANDA): 091416 application number: ANDA091416 ndc (product): 71610-436
NAPROXEN	NAPROXEN	Bryant Ranch Prepack	5d399bf3-db49-411a-91b9-b410d702a65a	2020-12-14	Warnings	Exact identifier application applno (ANDA): 091416 application number: ANDA091416
NAPROXEN	NAPROXEN	TIME CAP LABORATORIES	4350a2d9-5228-460e-b7b1-27e8fa846787	2018-10-09	Warnings	Exact identifier application applno (ANDA): 091416 application number: ANDA091416

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 2 of 2 · 89 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
71610-436	NAPROXEN	NAPROXEN	Aphena Pharma Solutions - Tennessee, LLC	ANDA	Current
72189-136	NAPROXEN	NAPROXEN	DIRECT RX	ANDA	Current
72189-136	NAPROXEN	NAPROXEN	DIRECT RX	ANDA	Current
72189-136	NAPROXEN	NAPROXEN	DIRECT RX	ANDA	Current
76420-042	NAPROXEN	NAPROXEN	Asclemed USA, Inc.	ANDA	Current
76420-042	NAPROXEN	NAPROXEN	Asclemed USA, Inc.	ANDA	Current
80425-0048	Naprosyn	Naproxen 375mg	Advanced Rx Pharmacy of Tennessee, LLC	ANDA	Current
80425-0048	Naproxen	Naproxen	Advanced Rx Pharmacy of Tennessee, LLC	ANDA	Current
80425-0048	Naproxen	Naproxen	Advanced Rx Pharmacy of Tennessee, LLC	ANDA	Current